Twist Bioscience Stock Surges 500% in One Year

South San Francisco, Sunday, 4 October 2026.
Twist Bioscience’s valuation soared to $12.5 billion in October 2026 following a 500% annual surge, fueled by demand for synthetic DNA and AI drug discovery partnerships.